Standout Papers
- Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia. (2018)
Immediate Impact
1 by Nobel laureates 7 from Science/Nature 65 standout
Citing Papers
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
2025 Standout
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
Works of Haiping Dai being referenced
Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.
2018 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Haiping Dai | 276 | 528 | 110 | 419 | 289 | 77 | 946 | |
| Beatriz Martín-Antonio | 261 | 379 | 27 | 656 | 274 | 49 | 1.2k | |
| Reuben Benjamin | 163 | 480 | 24 | 292 | 360 | 43 | 1.0k | |
| Toshinao Kawai | 169 | 262 | 51 | 476 | 161 | 49 | 905 | |
| Mar Bellido | 260 | 267 | 124 | 207 | 165 | 47 | 971 | |
| Éva Oláh | 166 | 229 | 140 | 154 | 353 | 84 | 1.0k | |
| Tae Kon Kim | 173 | 405 | 28 | 455 | 304 | 44 | 987 | |
| David Darling | 192 | 208 | 14 | 447 | 354 | 35 | 864 | |
| Antonia Busse | 178 | 560 | 99 | 453 | 487 | 52 | 1.1k | |
| M. Freund | 522 | 287 | 97 | 186 | 215 | 46 | 1.1k | |
| Udo F. Hartwig | 301 | 364 | 102 | 594 | 267 | 38 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...